Salesforce (NYSE:CRM – Get Free Report)’s stock had its “buy” rating reissued by equities researchers at Guggenheim in a research note issued on Thursday,Benzinga reports. They currently have a $228.00 target price on the CRM provider’s stock. Guggenheim’s price objective indicates a potential upside of 10.68% from the stock’s current price.
